Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03339 |
| Species: | Mus musculus |
| Position : | chr10:24165250-24167250 |
| Year: | 2018 |
| Title: | Multiple enhancer regions govern the transcription of CCN2 during embryonic development |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 29256171 |
| MONDO: | |
| Tissue: | Cartilage |
| Tissue Ontology ID: | UBERON:0002418 |
| Cell Source: | Chondrocytes |
| CVCL ID: | |
| Cell Type: | chondrocyte |
| Cell Ontology ID: | CL:0000138 |
| Experiment Type: | Transgenic reporter assay, Developmental regulation assay |
| High Throughput Method: | ChIP-seq |
| Low Throughput Method: | qRT-PCR, and ChIP-qPCR |
| Target gene : | Ccn2 |
| TF name : | Sox9 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Sox9 | Deactivation of the beta-catenin transactivating complex | reactome | 42 |
| Sox9 | TGF_beta_Receptor | netpath | 220 |
| Sox9 | Hs_Neural_Crest_Differentiation_WP2064_79263 | wikipathways | 40 |
| Sox9 | Hs_Spinal_Cord_Injury_WP2431_87678 | wikipathways | 21 |